Literature DB >> 17970722

Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain.

Veronica Di Fausto1, Marco Fiore, Paola Tirassa, Alessandro Lambiase, Luigi Aloe.   

Abstract

We have recently shown that conjunctivally applied nerve growth factor (NGF) in rats can reach the retina, the optic nerve and the CNS. In the present study, we investigated whether NGF application as collyrium can promote the recovery of chemically injured basal forebrain cholinergic neurons. NGF was administered on the eye of adult male mice previously treated i.c.v. with ibotenic acid to impair cholinergic pathways. Mice were tested in the passive avoidance test, and after 2 weeks of NGF administration were killed and the brains used for structural, biochemical and molecular analyses. The results showed that application of NGF on the eye surface protected choline acetyl transferase levels. These findings strengthen the hypothesis that application of NGF on the eye can represent an alternative delivery route to promote the recovery of brain cells during degeneration, including neurons involved in learning and memory activities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970722     DOI: 10.1111/j.1460-9568.2007.05883.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  12 in total

1.  The locus ceruleus responds to signaling molecules obtained from the CSF by transfer through tanycytes.

Authors:  Cheng-Yuan Feng; Larisa M Wiggins; Christopher S von Bartheld
Journal:  J Neurosci       Date:  2011-06-22       Impact factor: 6.167

2.  Autologous Serum Tears for Treatment of Photoallodynia in Patients with Corneal Neuropathy: Efficacy and Evaluation with In Vivo Confocal Microscopy.

Authors:  Shruti Aggarwal; Ahmad Kheirkhah; Bernardo M Cavalcanti; Andrea Cruzat; Clara Colon; Emma Brown; David Borsook; Harald Prüss; Pedram Hamrah
Journal:  Ocul Surf       Date:  2015-02-20       Impact factor: 5.033

3.  Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes.

Authors:  Gala Beykin; Laurel Stell; Muhammad Sohail Halim; Mariana Nuñez; Lilia Popova; Bac T Nguyen; Sylvia L Groth; Amy Dennis; Zhongqiu Li; Melissa Atkins; Tom Khavari; Sophia Y Wang; Robert Chang; Ann C Fisher; Yasir J Sepah; Jeffrey L Goldberg
Journal:  Am J Ophthalmol       Date:  2021-11-13       Impact factor: 5.488

Review 4.  Understanding Neuropathic Corneal Pain--Gaps and Current Therapeutic Approaches.

Authors:  Sunali Goyal; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

5.  Efficacy of autologous serum tears for treatment of neuropathic corneal pain.

Authors:  Shruti Aggarwal; Clara Colon; Ahmad Kheirkhah; Pedram Hamrah
Journal:  Ocul Surf       Date:  2019-01-24       Impact factor: 5.033

6.  Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.

Authors:  Alessandro Lambiase; Luigi Aloe; Marco Centofanti; Vincenzo Parisi; Sonia Nair Báo; Flavio Mantelli; Valieria Colafrancesco; Gian Luca Manni; Massimo Gilberto Bucci; Stefano Bonini; Rita Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-11       Impact factor: 11.205

Review 7.  Topical delivery of nerve growth factor for treatment of ocular and brain disorders.

Authors:  Gemma Eftimiadi; Marzia Soligo; Luigi Manni; Daniela Di Giuda; Maria Lucia Calcagni; Antonio Chiaretti
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

Review 8.  NGF, brain and behavioral plasticity.

Authors:  Alessandra Berry; Erika Bindocci; Enrico Alleva
Journal:  Neural Plast       Date:  2012-02-16       Impact factor: 3.599

9.  Intranasal nerve growth factor bypasses the blood-brain barrier and affects spinal cord neurons in spinal cord injury.

Authors:  Luigi Aloe; Patrizia Bianchi; Alberto De Bellis; Marzia Soligo; Maria Luisa Rocco
Journal:  Neural Regen Res       Date:  2014-05-15       Impact factor: 5.135

Review 10.  Nerve Growth Factor: A Focus on Neuroscience and Therapy.

Authors:  Luigi Aloe; Maria Luisa Rocco; Bijorn Omar Balzamino; Alessandra Micera
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.